Literature DB >> 31551343

Guidelines Support the Value of Stand-Alone Nucleic Acid Amplification Tests for Clostridioides (Clostridium) difficile Infection.

Fred C Tenover1, David H Persing2, Ferric Fang3.   

Abstract

Keywords:  Clostridioideszzm321990; Clostridiumzzm321990; Clostridium difficilezzm321990; PCR; toxin

Year:  2019        PMID： 31551343      PMCID： PMC6760941          DOI： 10.1128/JCM.01079-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  20 in total

1.  Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin.

Authors:  Dubert M Guerrero; Christina Chou; Lucy A Jury; Michelle M Nerandzic; Jennifer C Cadnum; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2011-08-01       Impact factor: 9.079

2.  Missed diagnosis of Clostridium difficile infection; a prospective evaluation of unselected stool samples.

Authors:  E Reigadas; L Alcalá; M Marín; A Burillo; P Muñoz; E Bouza
Journal:  J Infect       Date:  2014-11-05       Impact factor: 6.072

3.  Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.

Authors:  Anna Kaltsas; Matt Simon; Larissa H Unruh; Crystal Son; Danielle Wroblewski; Kimberlee A Musser; Kent Sepkowitz; N Esther Babady; Mini Kamboj
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

4.  Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay.

Authors:  Léa-Laurence Dionne; Frédéric Raymond; Jacques Corbeil; Jean Longtin; Philippe Gervais; Yves Longtin
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

5.  Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.

Authors:  S Erb; R Frei; A M Strandén; M Dangel; S Tschudin-Sutter; A F Widmer
Journal:  Clin Microbiol Infect       Date:  2015-07-29       Impact factor: 8.067

6.  Characteristics of Clostridium difficile infection in patients with discordant diagnostic test results.

Authors:  Antonio Ramos Martínez; Jorge Ortiz Balbuena; Ángel Asensio Vegas; Isabel Sánchez Romero; Elena Múñez Rubio; Mireia Cantero Caballero; Alberto Cózar Llistó; Francisca Portero Azorín; Rocío Martínez Ruiz
Journal:  Rev Esp Enferm Dig       Date:  2016-06       Impact factor: 2.086

7.  Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.

Authors:  Lee F Schroeder; Elizabeth Robilotti; Lance R Peterson; Niaz Banaei; David W Dowdy
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

8.  Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.

Authors:  Romney M Humphries; Daniel Z Uslan; Zachary Rubin
Journal:  J Clin Microbiol       Date:  2012-12-26       Impact factor: 5.948

9.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

10.  Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.

Authors:  Timothy D Planche; Kerrie A Davies; Pietro G Coen; John M Finney; Irene M Monahan; Kirsti A Morris; Lily O'Connor; Sarah J Oakley; Cassie F Pope; Mike W Wren; Nandini P Shetty; Derrick W Crook; Mark H Wilcox
Journal:  Lancet Infect Dis       Date:  2013-09-03       Impact factor: 25.071
View more
  1 in total

1.  Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.

Authors:  Carolyn D Alonso; Ciarán P Kelly; Kevin W Garey; Anne J Gonzales-Luna; David Williams; Kaitlyn Daugherty; Christine Cuddemi; Javier Villafuerte-Gálvez; Nicole C White; Xinhua Chen; Hua Xu; Rebecca Sprague; Caitlin Barrett; Mark Miller; Agnès Foussadier; Aude Lantz; Alice Banz; Nira R Pollock
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.